Study design: Comparative effectiveness review.
STUDY RATIONALE AND CONTEXT
Oncological treatment has undergone major evolution in the recent decades leading to decreased patient mortality. However, the rate of bony metastases has increased over the years [1] . The spine is among the most common location for bony metastases. In many cases these metastases cause fractures due to voids created by the treatment or by the tumor itself, leading to increased morbidity. Over the past decade percutaneous cement augmentation techniques have been developed for the treatment of these fractures. The two most common techniques are vertebroplasty and kyphoplasty. Vertebroplasty is a technique in which cement is injected into the vertebrae; kyphoplasty uses a balloon to create a void in the vertebrae into which the cement is injected. There are little data comparing these interventions.
CLINICAL QUESTION
Do comparative studies of vertebral cement augmentation for fractures due to spinal tumors provide evidence of improved patient outcomes?
METHODS

Study design: Comparative effectiveness review.
Search: PubMed, EMBASE, Cochrane Database of Systematic Reviews, bibliographies of key articles.
Dates searched: up through June 8, 2011.
Inclusion criteria:
Studies directly comparing cement augmentation via vertebroplasty or kyphoplasty with other treatment methods or with each other (CoE I-III) in patients with metastatic or primary tumors in the spine.
Exclusion criteria:
Spinal fractures due to trauma or osteoporosis; patients undergoing trauma surgery, decompression, or spinal fusion.
Outcomes: Pain, functional outcomes, longevity, hospitalization time, and complications.
Analysis: Descriptive statistics.
Additional methodological and technical details are provided in the Web Appendix at www.aospine.org/ebsj
RESULTS
Two small retrospective cohort studies (LoE-III; 83 patients, 147 levels) comparing vertebroplasty with kyphoplasty that met the inclusion criteria were identified and are summarized (Fig1) [2, 3] . Mean patient age was 62.5 years, women comprised 48.2% of the population, and the most common cancer diagnosis was primary multiple myeloma ( Table 1) . Additional details can be found in the Web Appendix at www. aospine.org/ebsj. A systematic review of vertebroplasty, kyphoplasty, and embolization for the treatment of spinal tumors was also identified [4] . Although the two studies identified by our search were included, this review primarily summarized case series and did not meet the inclusion criteria. Two additional systematic reviews [5, 6] that included many of the same case series were found and likewise did not meet inclusion criteria.
Total citations (N= 36)
4. Excluded at full-text review (n = 7)
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5. Included publications (n = 2)
2. Title/abstract (n = 27) * KP indicates kyphoplasty; VP, vertebroplasty; PMMA, polymethylmethacrylate; PVP, percutaneous vertebroplasty; and NR, not reported. † Loss of >50% or <50% of vertebral height on plain lateral x-ray. ‡ Several patients had risk factors for osteoporosis; it was often difficult to determine the extent to which this was responsible for vertebral body collapse compared with a purely osteolytic malignant process. § This group was excluded from analysis since only those patients who had one or the other procedure were included. ‡ Mean scores for pain-related disability. Patients were asked to evaluate five activities of daily living, ie, pain at rest, walking, sitting-standing, taking a shower, and wearing clothes, on a visual analogue scale (VAS) for pain (0-10). The sum of these five score created an overall VAS pain score that was evaluated on a scale of 0-50, with higher scores indicating greater disability because of pain. § Median scores on a VAS pain scale 0-10; estimated from figure 10 in the study. Follow-up at each interval: 41 (73%) at 1 month; 37 (66%) at 3 months; 21(38%) at 6 months; and 8(14%) at 1 year should be considered when interpreting these results.
Systematic review-Cement augmentation in spinal tumors (...)
Pain Pain scores for both the vertebroplasty and the kyphoplasty groups decreased significantly from preoperative values at follow-up intervals through 1 year ( Table 2 ) with a significantly greater percentage decrease in pain scores by 6 months and 1 year compared with vertebroplasty: 76.1% versus 68.1% (P = .02) and 73% versus 64.4% (P = .03), respectively (Fig 2) [3].
In the second study, based on an average of multiple VAS pain (0-10) measurements within the first 24 hours following vertebroplasty (35 sessions) and kyphoplasty (15 sessions), improvement was also seen in both groups [2] . Similar percentages treatment session for both resulted in improved or complete pain relief; vertebroplasty, 85.8% (n = 30 sessions) and kyphoplasty 80% (n = 12) (Fig 3) . Pain relief appears to have been sustained at 1-, 3-, 6-, and 12-month follow-up; however, follow-up rates dropped at each interval: 73% at 1 month; 66% at 3 months; 38% at 6 months; and 14% at 1 year. This needs to be considered when interpreting the results.
Analgesic use
One study reported that all patients receiving augmentation reduced weekly analgesic use at all postoperative times [3] . The other reported a significant change in the category of analgesics used at 1 month but this was not sustained at later follow-up [2] . Neither study reported on differences in analgesic use between treatment groups.
Complications
Balloon rupture occurred in one kyphoplasty patient in one study [3] . No other adverse outcomes, such as adjacent level fractures, intraoperative or postoperative neurological or pulmonary complications, were reported in either group. In the second study, extrusion of polymethylmethacrylate (PMMA) was noted on image intensifier during injection in six patients (17.6%) in the vertebroplasty group and no patients in the kyphoplasty group [2] . Extravasation of PMMA into the anterior perivertebral soft tissue was seen in one patient in the vertebroplasty group and no patients in the kyphoplasty group. No cement extravasation into the epidural space or neural foramen was reported in any patient in either group. No procedure-related deaths or intraoperative or perioperative complications were reported.
NS indicates not significant. * Patients were asked to evaluate five activities of daily living: pain at rest, walking, sitting-standing, taking a shower, and wearing clothes on a VAS for pain (0-10). The sum of these five score created an overall VAS pain score that was evaluated on a scale of 0-50, with higher scores indicating greater disability because of pain.
* Based on VAS pain scores within the first 24 hours. Multiple measurements during that period were averaged. Data available: vertebroplasty, n = 33 sessions; kyphoplasty, n = 13 sessions. Complete pain relief was reported for 8 (22.9%) vertebroplasty sessions and 1 (6.7%) kyphoplasty session.
Fig 3
Percentage of sessions resulting in pain relief during the first 24 hours, * vertebroplasty or kyphoplasty reported by Fourney et al [2] (N = 49). 
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Evidence-Based Spine-Care Journal There are risks involved, including cement leakage causing spinal cord compression which may require urgent or emergency surgical intervention [7] ."
Recommendations:
Consider vertebroplasty or kyphoplasty for patients who have vertebral metastases and no evidence of metastatic spinal cord compression or spinal instability if they have: -mechanical pain resistant to conventional analgesia, or -vertebral body collapse. Vertebroplasty or kyphoplasty for spinal metastases should only be performed after agreement between appropriate specialists (including an oncologist, interventional radiologist, and spine surgeon) with full involvement of the patient and in facilities with good access to spine surgery.
ILLUSTRATIVE CASE
A 66-year-old man with known metastatic renal cell carcinoma (clear cell) presented with back pain. An x-ray revealed pathological fractures in the T9 and T7 vertebrae (Fig 4) . The patient was treated with oral narcotics but the pain did not resolve, so kyphoplasty of T9 and T7 with cement augmentation of T8 was performed under general anesthesia (Figs 5 and 6) . A postoperative computed tomography showed good filling of the vertebrae without penetration (Fig 7) . Following the procedure, the patient's pain subsided and he regained full mobility allowing improved quality of life. 
Systematic review-Cement augmentation in spinal tumors (...)
The review by Mendel et al [4] primarily included case series. Data specific to patients with tumors were summarized as follows ( Tables 3-5 Data from two other systematic reviews suggests the following ( Tables 3-5 ) [5, 6] : Cement leakage is much more common following vertebroplasty compared with kyphoplasty with up to 79% versus 6% of patients experiencing this, respectively; however, few symptomatic leaks were noted in either group, 0.26% versus 0%, respectively. New fractures occurred in 10.2% of patients based on pooled estimates across four reports on kyphoplasty [5] .
DISCUSSION
There is limited information from comparative studies on the benefits and harms of cement augmentation methods for the treatment of tumor-related fractures. Both procedures adequately provide pain management, the main indication for the procedure. In many studies, vertebral body height is better restored with kyphoplasty. The included study by Fourney et al [2] reported a mean percentage of restored height of 42% ± 21%. In this analysis the benefit of kyphoplasty could not be determined and the link between height and functional outcomes was not evaluated.
Conclusions from this review of the two comparative studies identified are limited by the following: -Pain outcomes and analgesic use were defined differently making comparisons across them difficult. Definitions for clinically meaningful changes in pain score were not described in either study. The small sample sizes may preclude the evaluation of rare complications and preclude meaningful statistical analysis. -Neither study was designed to rigorously compare vertebroplasty and kyphoplasty. Treatment selection based on patient presentation may lead to biased results for comparison. -Significant loss to follow-up in the one study and inability to determine the number of eligible patients (and therefore loss to follow-up) should be considered when interpreting these results and drawing conclusions about sustained benefits.
Evidence-Based Spine-Care Journal
Systematic review-Cement augmentation in spinal tumors (...) Table 5 Other complications from systematic reviews. 
